News | November 11, 2025
The said inspection concluded with Zero Form 483 observation
Relmada expects to initiate its Phase 3 program in the first half of 2026
The device delivers clear, high-quality images to support accurate diagnoses across a broad range of patient groups
Senores Pharmaceuticals (SPI) acquired 51% stake in Zoraya Pharmaceuticals
Oral semaglutide 25 mg was associated with the same weight loss efficacy in women with obesity regardless of menopausal stage, and patients reported improvements in physical function, respectively
Enzomenib, an oral, small-molecule inhibitor designed to disrupt the menin-MLL protein interaction involved in leukemogenesis
The study demonstrated strong clinical outcomes, with 94.8 per cent of subjects remaining free from major target limb amputation at one year
Teva reported third quarter revenues of $4.5 billion, an increase of 3 per cent year-over-year.
From material selection to cooling tower management, every small decision affects long-term equipment reliability
Subscribe To Our Newsletter & Stay Updated
